NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/27/2022
Back to search
Official data from USPTO
MNM BIOSCIENCE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
MNM BIOSCIENCE
ST13
US500000090847854Class
42, 44
Filing
90847854
Registration
6933514
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
19
Latest update
12/27/2022
Trademark type
Word
Nice classes
42, 44
Filing date
07/26/2021
Registration date
12/27/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/27/2022
Last transaction
12/27/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
07/10/2021
First use in commerce
07/10/2021
Drawing code
4
Owner type
03
Owner location
Cambridge, MA
Examiner
TANNER, MICHAEL
Law office
N10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
MNM Bioscience, Inc.
Representatives
Ryan Wertman GROWTHCOUNSEL LLC
Technical classification
Nice Classes
Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Genetic research; genetic engineering services; scientific research in the field of genetics and genetic engineering; scientific research in the field of biotechnology; biotechnology testingthe use AI-powered whole genome sequencing for scientific and medical research use to analyze tumor biology; research and development in the field of biotechnology; design and writing of computer programs for biotechnological applications for others; research and development in the pharmaceutical and biotechnology fields; providing scientific research information in the field of biochemistry and biotechnology; Providing information about medical and scientific research in the fields of cancervaccines and medical diagnostic instruments
Class 44
Biotechnology testingthe use of AI-powered whole genome sequencing for medical diagnostic and treatment purposes to analyze tumor biology; genetic testing for medical diagnostic and treatment purposes; genetic testing for medical diagnostic and treatment purposes to determine the appropriate medical antineoplastic therapy
Publications
History of USPTO decisions and trademark events.
19 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
12/27/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/11/2022
PUBO
PUBLISHED FOR OPPOSITION
10/11/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/21/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/08/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
08/15/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
08/15/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
08/15/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
08/15/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/01/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/31/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/31/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/22/2022
GNRT
NON-FINAL ACTION E-MAILED
04/22/2022
CNRT
NON-FINAL ACTION WRITTEN
04/22/2022
DOCK
ASSIGNED TO EXAMINER
04/20/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/24/2021
NWAP
NEW APPLICATION ENTERED
07/29/2021
Continuous trademark protection
Get notified about every new filing that threatens MNM BIOSCIENCE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.